Last reviewed · How we verify
NCT05052788
OCT Angio in Cerebral Small Vessel Disease
trial testing Optical coherence tomography angiography in Cerebral Small Vessel Disease and OCT Angio in 60 participants. Status unknown.
1 December 2021
Quick facts
| Lead sponsor | Ain Shams University |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 60 |
| Start date | 1 October 2021 |
| Primary completion | 1 December 2021 |
| Estimated completion | 1 January 2022 |
Drugs / interventions tested
- Optical coherence tomography angiography
Conditions studied
- Cerebral Small Vessel Disease and OCT Angio — all drugs for Cerebral Small Vessel Disease and OCT Angio →
Sponsor
Ain Shams University
Who can join
50 and older, any sex, with Cerebral Small Vessel Disease and OCT Angio. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of the study is to: - detect changes in retinal structure and microvasculature in patients with cerebral small vessel disease using optical coherence tomography angiography , correlate these changes with brain imaging markers and determine if ( OCTA ) can be used as a screening tool for cerebral small vessel disease.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05052788
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Optical coherence tomography angiography
Trials testing the same drug.
- NCT06460142 — Assessing Biomarker in Giant Cell Arteritis and Polymyalgia Rheumatic · recruiting
- NCT07419776 — The Effect Of Polycystic Ovarian Syndrome Treatment On Ocular Surface. · completed
- NCT06000176 — Comparison of Optical Coherence Tomography Angiography Microvascular Changes in Primary Open Angle and Primary Angle Clo · completed
- NCT04601012 — OCTA Study: Retinal Vascular Changes in Patients With SARS-CoV-2 Infection · completed
- NCT04488887 — OCTA Metrics Repeatability and Reproducibility in Different Disorders · unknown
Other Ain Shams University trials
Trials by the same sponsor.
- NCT07435493 — Fentanyl Versus Opioid Free Multimodal Analgesia for Perioperative Pain Control in Children With Mild to Moderate Obstru · NA · not yet recruiting
- NCT07482540 — Role of Dexmedatomidine Drug in Prevention of Atrial Fibrillations Post Mitral Valve Surgery · NA · not yet recruiting
- NCT07531030 — Posterior Pericapsular Deep Gluteal Block Combined With Pericapsular Nerve Group and Lateral Femoral Cutaneous Nerve Blo · NA · not yet recruiting
- NCT06839027 — Arterial to Central co2gap in Relation to Outcome After Cardiopulmonary Bypass · not yet recruiting
- NCT07516535 — DISS vs FANS in Suction-Assisted RIRS for Medium-Sized Renal Stones · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05052788 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Ain Shams University
- Last refreshed: 29 September 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05052788.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing